DEAWL 发表于 2025-3-26 21:10:42
http://reply.papertrans.cn/39/3804/380304/380304_31.png勤劳 发表于 2025-3-27 02:29:37
http://reply.papertrans.cn/39/3804/380304/380304_32.pngBiofeedback 发表于 2025-3-27 07:40:57
http://reply.papertrans.cn/39/3804/380304/380304_33.pngNeonatal 发表于 2025-3-27 12:15:42
Biomarker-Targeted Confirmatory Trialsnt design only enrolls patients tested positive for the biomarker and is often the most efficient and ethical approach when there is established evidence that treatment benefit is restricted to the biomarker positive group. On the other hand, when there is inadequate evidence that treatment benefitBrittle 发表于 2025-3-27 15:24:28
http://reply.papertrans.cn/39/3804/380304/380304_35.pngenfeeble 发表于 2025-3-27 21:31:39
http://reply.papertrans.cn/39/3804/380304/380304_36.png